Synopsis:
Dolly Khanna increased her stake in Mangalore Chemicals & Fertilizers to 3.33 percent in June 2025, up from 2.18 percent in March, signalling growing confidence.
In Monday’s trading session, shares of a leading fertiliser company surged nearly 8.5 percent, touching a fresh record high of Rs. 310 on the BSE. The sharp rally was largely driven by news that a well-known investor increased its stake in the company, a detail that caught the market’s attention and is explained further in this article.
At 01:47 p.m., the shares of Mangalore Chemicals & Fertilizers Limited were trading in the green at Rs. 302.4 on BSE, up by around 6percent, as against its previous closing price of Rs. 285.75, with a market cap of Rs. 3,584 crores. The stock has delivered multibagger returns of around 141 percent in the last one year, and has gained by over 11 percent in one month.
What’s the News
According to the June 2025 shareholding disclosures on the BSE, the ace investor Dolly Khanna raised her stake in Mangalore Chemicals & Fertilizers Limited to 3.33 percent. This marks a rise from her 2.18 percent holding in March 2025, an increase of 1.15 percent over the last quarter.
Mangalore Chemicals and Fertilizers Limited, a subsidiary of Zuari Fertilisers and Chemicals Limited (an Adventz Group), is primarily engaged in the business of manufacturing Ammonia, Urea, Di-ammonium Phosphate, and Ammonium bicarbonate. The main product, Urea, is marketed under the brand ‘Mangala’.
As of May 2025, the company’s production capacity stands at 3.8 lakh metric tonnes (LMT) for Urea and 2.85 LMT for DAP and complex fertilisers. Its manufacturing plant is located on the west coast in Mangalore, opposite the Mangalore Port.
Written by Shivani Singh
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
